Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
about
Breast Cancer Genetic Counseling: A Surgeon's PerspectiveThe Consequences of a BRCA Mutation in WomenGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineGenetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis.BRCA1/2 genetic testing uptake and psychosocial outcomes in men.Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high riskWhy is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia.Communication and technology in genetic counseling for familial cancer.Cancer worry among Norwegian male BRCA1/2 mutation carriers.Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.Communication of BRCA results and family testing in 1,103 high-risk women.Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing.Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriersA Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome.Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling.Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directionsExploring resources for intrafamilial communication of cancer genetic risk: we still need to talk.Counsellee's experience of cancer genetic counselling with pedigrees that automatically incorporate genealogical and cancer database information.Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study.Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients.Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study.Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.Components of family history associated with women's disease perceptions for cancer: a report from the Family Healthware™ Impact Trial.Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.Implementation of a risk assessment program in a breast-imaging community practice.Gendered Cultural Identities: The Influences of Family and Privacy Boundaries, Subjective Norms, and Stigma Beliefs on Family Health History Communication.Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families.Engagement with Genetic Information and Uptake of Genetic Testing: the Role of Trust and Personal Cancer History.Communicating BRCA1/2 genetic test results within the family: a qualitative analysis.Intuition versus cognition: a qualitative exploration of how women understand and manage their increased breast cancer risk.Communication Between Breast Cancer Patients Who Received Inconclusive Genetic Test Results and Their Daughters and Sisters Years After Testing.Development of the Informing Relatives Inventory (IRI): Assessing Index Patients' Knowledge, Motivation and Self-Efficacy Regarding the Disclosure of Hereditary Cancer Risk Information to Relatives.Family communication following BRCA1/2 genetic testing: a close look at the process.
P2860
Q26767380-ECF4C9C5-A93E-460C-A0C6-CAADB7D5EEB8Q26777891-279FE575-270E-4223-9B7E-E49321D4B895Q30513982-8B462BD8-F12B-42E1-9914-7AAE7344655EQ33564013-7C0EAB70-D54F-4F83-9921-B06C39A09AA2Q34351351-719FBD9D-F274-4141-8B8E-757BB64D7B2DQ34410245-7B159394-77AF-4C92-823A-E0205E3462B6Q35131147-B53838E6-3EC1-41DE-A12A-0B16AA1B6AA5Q35164851-66B5F664-0716-497E-9E78-8F7D7065BA6EQ35194662-2BF9C019-769D-4379-B759-EB8D31A3AC56Q35212286-361A48C7-D95C-46AA-8CF0-D09B169E05C1Q35219186-3D323CF7-06EF-4D8A-84A9-3D369B8C4A40Q35513354-3EE0E0D6-5202-4FA9-845A-D3F739D951FCQ35519321-B71E1006-A1E0-491A-AB3F-DA05CD4ADD2DQ35570884-056CF46E-3127-454C-9DB5-161EC61F6FE5Q35907075-8E038AFA-D766-4D5A-AB0A-9EAA3EC22760Q35956823-E4D9E601-305B-46AF-B7F5-E7FB10C53735Q36110947-EE9C9EE5-7975-44D7-A042-BC83B86E45E2Q36997274-1325A95B-F236-4227-A1FA-D670E9D1CD19Q37069898-9B930980-3082-4F92-B217-50BF302CB931Q37078248-DB7811CB-01CE-4F04-BAF4-4CBBD392A112Q37102122-7DF334EC-042E-40A0-B0EF-DAF39614988EQ37124135-3A6D4A06-DE23-4E27-A2AE-1325A3A4EBC8Q37227896-F14440C9-8E64-42C6-847E-67E0C67A3DB2Q37231061-0B7C811E-247F-47A6-B728-3DC0D29364A6Q37237966-8B2D15AB-4837-41F3-8CE9-5E170EC259F2Q37312028-388927ED-97C7-4F90-A3E8-1D803A59557AQ37455318-F88C978E-85EF-427D-8488-F390CDC45819Q37590233-BCEA5A74-3A78-4109-BBEE-EAF8256BA8A8Q37590728-B87ED145-11FC-4506-91A8-53321AAEF56DQ37715010-69A467BC-77FE-4885-BDF4-B5E56F68B149Q37746657-DFB54E8E-0340-4DA1-9FF7-3364714A8FC1Q38257304-C0B0F2DF-CEA7-4342-B9BE-22931FE83763Q38679300-8BCFE966-367C-4771-A5A4-43F5C8FE91ACQ38685321-7EBCE8A6-9D4A-42A8-AAAE-8555BDC783D7Q39010918-0837F027-2160-432F-AE89-D9EFC82AB3F7Q39289151-0461A2E0-B3E9-41DF-A6CE-2A8BFB7F987EQ41143496-744550C7-5064-4A30-A0EA-6F5E20C0680CQ41251109-1061769B-90F6-447E-AC6B-F87C014D6351Q41681625-6691EBBE-D0AF-4FF5-8015-53AADBAC3848Q43940234-6559AD73-06CF-45CB-8543-8D00B81A37DF
P2860
Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Factors determining disseminat ...... with known BRCA1/2 mutations.
@ast
Factors determining disseminat ...... with known BRCA1/2 mutations.
@en
Factors determining disseminat ...... with known BRCA1/2 mutations.
@nl
type
label
Factors determining disseminat ...... with known BRCA1/2 mutations.
@ast
Factors determining disseminat ...... with known BRCA1/2 mutations.
@en
Factors determining disseminat ...... with known BRCA1/2 mutations.
@nl
prefLabel
Factors determining disseminat ...... with known BRCA1/2 mutations.
@ast
Factors determining disseminat ...... with known BRCA1/2 mutations.
@en
Factors determining disseminat ...... with known BRCA1/2 mutations.
@nl
P2093
P2860
P356
P1476
Factors determining disseminat ...... with known BRCA1/2 mutations.
@en
P2093
Barbara L Weber
Eric Burlingame
Esme Finlay
Jill E Stopfer
Katherine Goldfeder Evans
Katrina Armstrong
Timothy R Rebbeck
P2860
P356
10.1089/GTE.2007.0037
P577
2008-03-01T00:00:00Z